PGXL Email Format
Biotechnology ResearchKentucky, United States11-50 Employees
PGXL is a biotechnology research company focused on pharmacogenetics and molecular diagnostics, offering a range of pharmacogenetic and anatomic pathology testing for personalized medicine, alongside research services for drug and device developers. Based in Louisville, Kentucky, the firm positions itself in the pharmacogenetics and molecular diagnostics space, serving clients who require genetic-guided approaches to therapy and diagnostic testing to support product development. The organization is recognized for its historical role as a pioneer in pharmacogenetics testing and was noted as the first CLIA-certified laboratory dedicated to this testing area. In recent developments, PGXL was reported to have been acquired by Prescient Medicine in October 2017, signaling a strategic partnership within the predictive health intelligence landscape. The company operates with a relatively small, specialized team and serves international clients seeking advanced pharmacogenetic insights and pathology services to inform personalized treatment and development programs.